Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Induction of a cellular migration program through protease-activated receptor 2 activation in primary colonic epithelial cells
EF 2016-17
Résumé
The inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis are chronic diseases that affect many people in westernized nations and are shown to be increasing in prevalence worldwide. These diseases affect ~250 000 Canadians and contribute to a significant economic burden of $2.8 billion annually, plus the incalculable costs of patient suffering. We know that a class of enzymes called proteases are present in the inflammatory milieu at the level of the intestinal epithelium and are involved in the host-response to inflammation. A receptor of these enzymes, protease-activated receptor 2 (PAR2), is expressed in intestinal epithelial cells, and studies suggest that PAR2 activation may mediate epithelial cell proliferation, an important part of the healing process. Our novel proposal addresses the interaction of proteases and PAR2 activation in intestinal epithelial cells and how these interactions drive epithelial repair and mucosal healing. We hypothesize that activation of PAR2 induces a cellular migration program in intestinal epithelial cells that enhances mucosal healing. Having this information will inform future targeted studies for the development of new drugs to treat IBD.It is important to note that this proposal was designed to enable translation of our findings into IBD patient samples. These studies apply a multifaceted approach to investigate the genetic level, the level of cell-cell interactions, and eventually intestinal healing in patient samples. It is hoped that by characterizing the role of PAR2-induced wound healing, novel therapeutic targets and cellular programs will be revealed in an effort to ameliorate symptoms of IBD, a debilitating chronic disease with a substantial economic impact.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
367384
Name
Vegso Andrew J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Induction of a cellular migration program through protease-activated receptor 2 activation in primary colonic epithelial cells
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cellular Migration; Crohn'S Disease; Inflammation; Intestinal Healing; Intestinal Wounding; Protease Activated Receptor 2; Ulcerative Colitis
Abstract
The inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis are chronic diseases that affect many people in westernized nations and are shown to be increasing in prevalence worldwide. These diseases affect ~250 000 Canadians and contribute to a significant economic burden of $2.8 billion annually, plus the incalculable costs of patient suffering. We know that a class of enzymes called proteases are present in the inflammatory milieu at the level of the intestinal epithelium and are involved in the host-response to inflammation. A receptor of these enzymes, protease-activated receptor 2 (PAR2), is expressed in intestinal epithelial cells, and studies suggest that PAR2 activation may mediate epithelial cell proliferation, an important part of the healing process. Our novel proposal addresses the interaction of proteases and PAR2 activation in intestinal epithelial cells and how these interactions drive epithelial repair and mucosal healing. We hypothesize that activation of PAR2 induces a cellular migration program in intestinal epithelial cells that enhances mucosal healing. Having this information will inform future targeted studies for the development of new drugs to treat IBD.It is important to note that this proposal was designed to enable translation of our findings into IBD patient samples. These studies apply a multifaceted approach to investigate the genetic level, the level of cell-cell interactions, and eventually intestinal healing in patient samples. It is hoped that by characterizing the role of PAR2-induced wound healing, novel therapeutic targets and cellular programs will be revealed in an effort to ameliorate symptoms of IBD, a debilitating chronic disease with a substantial economic impact.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vegso, Andrew J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~